CME Group Inc. Reports Mixed Results in Recent Analysis

CME Group Inc. has received a 62% rating based on its fundamentals from a recent report. While it scored well in earnings and revenue growth, several criteria such as sales growth and long-term earnings persistence raised concerns, potentially impacting investor sentiment.

Date: 14-09-2024

AI Rating: 5

The report highlights CME Group Inc. as a large-cap growth stock in the Investment Services industry, assessing it under the Growth Investor model, attributed to Martin Zweig. The stock's overall rating stands at 62%. This score signals a cautious interest from analysts, as scores below 80% indicate lesser confidence in stock performance.

In terms of Revenue Growth, the report indicates that while the company has a positive EPS growth rate for the current quarter, it has failed to show consistent Sales Growth Rate and long-term EPS Growth. Specifically:

P/E Ratio: PASS
Revenue Growth in relation to EPS Growth: PASS
Sales Growth Rate: FAIL
Current Quarter Earnings: PASS
Quarterly Earnings One Year Ago: PASS
Positive Earnings Growth Rate for Current Quarter: PASS
EPS Growth for Current Quarter must be greater than prior 3 quarters: PASS

However, the report notes red flags in areas of earnings performance:

Earnings Growth Rate for the Past Several Quarters: FAIL
EPS Growth for Current Quarter must be greater than the Historical Growth Rate: FAIL
Earnings Persistence: FAIL
Long-Term EPS Growth: FAIL

These issues could pose risks for potential investors, as signs of instability in earnings could lead to decreased market confidence. The rating based on these aspects could ultimately affect CME Group Inc.'s stock price adversely in the short to medium term.

Stocks: CME